Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)
Hong Kong
· Delayed Price · Currency is HKD
24.50
-0.20 (-0.81%)
At close: Apr 25, 2025, 4:00 PM HKT
HKG:2480 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 64.8 | 87.01 | 85.83 | 60.22 |
| Research & Development | 135.13 | 172.69 | 91.43 | 42.98 |
| Other Operating Expenses | 0.75 | 0.6 | 3.14 | 9.04 |
| Operating Expenses | 200.67 | 260.3 | 180.39 | 112.24 |
| Operating Income | -200.67 | -260.3 | -180.39 | -112.24 |
| Interest Expense | -1.44 | -0.84 | -0.72 | -0.6 |
| Interest & Investment Income | 3.52 | 6.01 | 0.25 | 0.04 |
| Currency Exchange Gain (Loss) | 1 | 6.73 | 1 | 0 |
| Other Non Operating Income (Expenses) | 18.55 | -12.38 | -559.41 | -437.35 |
| EBT Excluding Unusual Items | -179.06 | -260.78 | -739.28 | -550.15 |
| Gain (Loss) on Sale of Investments | 11.1 | 11.38 | 13.87 | 10.8 |
| Gain (Loss) on Sale of Assets | -0.25 | 0.06 | -0 | -0.01 |
| Other Unusual Items | -0.03 | - | 0.24 | - |
| Pretax Income | -168.24 | -249.35 | -725.18 | -539.36 |
| Net Income | -168.24 | -249.35 | -725.18 | -539.36 |
| Net Income to Common | -168.24 | -249.35 | -725.18 | -539.36 |
| Shares Outstanding (Basic) | 202 | 199 | 146 | 91 |
| Shares Outstanding (Diluted) | 202 | 199 | 146 | 91 |
| Shares Change (YoY) | 1.48% | 36.65% | 60.39% | - |
| EPS (Basic) | -0.83 | -1.25 | -4.98 | -5.94 |
| EPS (Diluted) | -0.83 | -1.25 | -4.98 | -5.94 |
| Free Cash Flow | -180.45 | -275.72 | -285.47 | -79.08 |
| Free Cash Flow Per Share | -0.89 | -1.39 | -1.96 | -0.87 |
| EBITDA | -179.15 | -248.65 | -174.97 | -109.42 |
| D&A For EBITDA | 21.53 | 11.65 | 5.42 | 2.83 |
| EBIT | -200.67 | -260.3 | -180.39 | -112.24 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.